Mark,

I disagree that NCS is a success from an investors persperctive. Although Exypnotech is moving forward, it is doing nothing for shareholder value.

My significant investment in Nanopierce was placed almost eight years ago. All of the overly optimistic projections, and in some cases less than honest reports, have resulted in nothing significant for shareholders.

"Bemoan an unmet past"? If you mean taking a look at the optimism of the past and weighing it against the rewards to shareholders, there is reason for dissatisfaction. Other than proven performance leading to increased shareholder value (i.e. share price), what on earth would motivate any long to reset his "anticipation clock"?

My only point is that new investors should make themselves aware of Nanopierce's past. If eight years is too narrow a window for success, maybe someone can share their view of what window may be expected for Vyta.

Jeff